MedTrace Logo

Oxygen Therapy and Pregnancy in Sickle Cell Disease

NCT02813850 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 178

Last updated 2025-11-20

No results posted yet for this study

Summary

The purpose of this study is to assess the efficiency of the preventive oxygen therapy on the occurrence of vaso-occlusive complications, which last more than 24 hours and require hospitalisation, in women with sickle cell disease.

Conditions

Interventions

DEVICE

oxygen therapy

Oxygen therapy early in the night (2L/min) during 4hours per days

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Alexandra BENACHI, MD, PhD · Assistance Publique - Hôpitaux de Paris

  • Laure JOSEPH, MD,PhD · Assistance Publique - Hôpitaux de Paris

  • Marina CAVAZZANA, MD, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-05
Primary Completion
2021-12-03
Completion
2022-08-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02813850 on ClinicalTrials.gov